Skip to main content

Table 3 Distribution of BT-RADS category 3 and ADCmean among recurrent and non-recurrent glioma patients

From: The value of adding DWI and FLAIR signal changes in the resection cavity on the diagnostic performance of BT-RADS category 3 for tumor progression prediction in post-treated glioma patients: a prospective pilot study

Variables

Number

Final diagnosis

P-value

Recurrence

Non-recurrence

Number (%)

ADC value mean (range)

Number (%)

ADC value mean (range)

BT-RADS 3a

2

0 (0)

0

2 (13.3)

1.5 (1.4–1.6) × 10−3 mm/s

< 0.001

BT-RADS 3b

20

9 (69.2)

0.9 (0.7–1.40) × 10−3mm2/s

11 (78.6)

1.2 (1–1.6) × 10−3 mm/s

 

BTIRADS 3c

5

4 (30.1)

0.8 (0.7–0.9) × 10−3mm2/s

1(7.1)

1.1 × 10−3 mm/s

 

Total

27

13(48.1)

0.9 (0.7–1.4) × 10−3mm2/s

14(51.9)

1.15 (1.04–1.6) × 10−3 mm/s